Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity
Abstract Fungal pathogens are considered as serious factors for deadly diseases and are a case of medical concern. Invasive fungal infections also complicate the clinical course of COVID-19, leading to a significant increase in mortality. Furthermore, fungal strains' multidrug resistance has increas...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Nature Portfolio
2024-02-01
|
| Sraith: | Scientific Reports |
| Rochtain ar líne: | https://doi.org/10.1038/s41598-024-54252-0 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
